Pipecuronium bromide

Pipecuronium bromide is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It is grouped under the following drug class(es): Neuromuscular blocking agents. Its therapeutic use is listed as muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Arduan and Pipecurium bromide. Its PubChem CID is 65332.

CAS No 52212-02-9
Molecular Formula C35H62Br2N4O4
Molecular Weight 762.7 g/mol
Synonyms [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide

Frequently Asked Questions